CURLF
Price
$2.85
Change
+$0.05 (+1.79%)
Updated
Sep 5 closing price
Capitalization
2.21B
63 days until earnings call
CXXIF
Price
$0.34
Change
+$0.02 (+6.25%)
Updated
Sep 5 closing price
Capitalization
39.27M
Interact to see
Advertisement

CURLF vs CXXIF

Header iconCURLF vs CXXIF Comparison
Open Charts CURLF vs CXXIFBanner chart's image
Curaleaf
Price$2.85
Change+$0.05 (+1.79%)
Volume$502.84K
Capitalization2.21B
C21 Investments
Price$0.34
Change+$0.02 (+6.25%)
Volume$41.22K
Capitalization39.27M
CURLF vs CXXIF Comparison Chart in %
Loading...
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CXXIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CURLF vs. CXXIF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURLF is a Hold and CXXIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (CURLF: $2.85 vs. CXXIF: $0.34)
Brand notoriety: CURLF and CXXIF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CURLF: 38% vs. CXXIF: 26%
Market capitalization -- CURLF: $2.21B vs. CXXIF: $39.27M
CURLF [@Pharmaceuticals: Generic] is valued at $2.21B. CXXIF’s [@Pharmaceuticals: Generic] market capitalization is $39.27M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CURLF’s FA Score shows that 0 FA rating(s) are green whileCXXIF’s FA Score has 1 green FA rating(s).

  • CURLF’s FA Score: 0 green, 5 red.
  • CXXIF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CURLF and CXXIF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CURLF’s TA Score shows that 3 TA indicator(s) are bullish while CXXIF’s TA Score has 4 bullish TA indicator(s).

  • CURLF’s TA Score: 3 bullish, 5 bearish.
  • CXXIF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CXXIF is a better buy in the short-term than CURLF.

Price Growth

CURLF (@Pharmaceuticals: Generic) experienced а -13.64% price change this week, while CXXIF (@Pharmaceuticals: Generic) price change was -20.33% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.10%. For the same industry, the average monthly price growth was +9.00%, and the average quarterly price growth was +87.12%.

Reported Earning Dates

CURLF is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CURLF($2.21B) has a higher market cap than CXXIF($39.3M). CURLF YTD gains are higher at: 82.692 vs. CXXIF (70.500). CURLF has higher annual earnings (EBITDA): 220M vs. CXXIF (4.72M). CURLF has more cash in the bank: 102M vs. CXXIF (2.66M). CXXIF has less debt than CURLF: CXXIF (12.9M) vs CURLF (843M). CURLF has higher revenues than CXXIF: CURLF (1.29B) vs CXXIF (32.1M).
CURLFCXXIFCURLF / CXXIF
Capitalization2.21B39.3M5,613%
EBITDA220M4.72M4,660%
Gain YTD82.69270.500117%
P/E RatioN/AN/A-
Revenue1.29B32.1M4,006%
Total Cash102M2.66M3,842%
Total Debt843M12.9M6,535%
FUNDAMENTALS RATINGS
CURLF vs CXXIF: Fundamental Ratings
CURLF
CXXIF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
3436
P/E GROWTH RATING
1..100
1007
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CURLF's Valuation (49) in the null industry is somewhat better than the same rating for CXXIF (98). This means that CURLF’s stock grew somewhat faster than CXXIF’s over the last 12 months.

CURLF's Profit vs Risk Rating (100) in the null industry is in the same range as CXXIF (100). This means that CURLF’s stock grew similarly to CXXIF’s over the last 12 months.

CXXIF's SMR Rating (95) in the null industry is in the same range as CURLF (97). This means that CXXIF’s stock grew similarly to CURLF’s over the last 12 months.

CURLF's Price Growth Rating (34) in the null industry is in the same range as CXXIF (36). This means that CURLF’s stock grew similarly to CXXIF’s over the last 12 months.

CXXIF's P/E Growth Rating (7) in the null industry is significantly better than the same rating for CURLF (100). This means that CXXIF’s stock grew significantly faster than CURLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CURLFCXXIF
RSI
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CXXIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FAIRX33.660.46
+1.39%
Fairholme
VSENX55.570.22
+0.40%
JPMorgan Small Cap Equity R6
GGIJX13.170.05
+0.38%
Goldman Sachs Global Infras R6
HWMIX57.28-0.09
-0.16%
Hotchkis & Wiley Mid-Cap Value I
VLACX120.64-0.38
-0.31%
Vanguard Large Cap Index Investor

CURLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CURLF has been closely correlated with GTBIF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURLF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CURLF
1D Price
Change %
CURLF100%
+1.79%
GTBIF - CURLF
82%
Closely correlated
+4.55%
TCNNF - CURLF
78%
Closely correlated
+4.55%
VRNOF - CURLF
76%
Closely correlated
+5.51%
CRLBF - CURLF
73%
Closely correlated
+5.26%
TSNDF - CURLF
73%
Closely correlated
+13.08%
More

CXXIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CXXIF has been loosely correlated with CRLBF. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CXXIF jumps, then CRLBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CXXIF
1D Price
Change %
CXXIF100%
+6.76%
CRLBF - CXXIF
53%
Loosely correlated
+5.26%
CURLF - CXXIF
52%
Loosely correlated
+1.79%
GTBIF - CXXIF
52%
Loosely correlated
+4.55%
TCNNF - CXXIF
51%
Loosely correlated
+4.55%
TSNDF - CXXIF
51%
Loosely correlated
+13.08%
More